This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2011 May 17;57(20):2029-30.

doi: 10.1016/j.jacc.2010.12.009.

Optimizing pharmacotherapy for limiting cardiovascular remodeling a matter of timing therapy to match biology

PMID: 21565640
DOI: 10.1016/j.jacc.2010.12.009

Free article

Editorial

Optimizing pharmacotherapy for limiting cardiovascular remodeling a matter of timing therapy to match biology

Bodh I Jugdutt. J Am Coll Cardiol. 2011.

Free article

. 2011 May 17;57(20):2029-30.

doi: 10.1016/j.jacc.2010.12.009.

Author

PMID: 21565640
DOI: 10.1016/j.jacc.2010.12.009

No abstract available

PubMed Disclaimer

Comment on

The primary benefits of angiotensin-converting enzyme inhibition on cardiac remodeling occur during sleep time in murine pressure overload hypertrophy.
Martino TA, Tata N, Simpson JA, Vanderlaan R, Dawood F, Kabir MG, Khaper N, Cifelli C, Podobed P, Liu PP, Husain M, Heximer S, Backx PH, Sole MJ. Martino TA, et al. J Am Coll Cardiol. 2011 May 17;57(20):2020-8. doi: 10.1016/j.jacc.2010.11.022. J Am Coll Cardiol. 2011. PMID: 21565639

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

IAP99003/Canadian Institutes of Health Research/Canada

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science